VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $915,000 | -83.3% | 9,100 | -70.2% | 0.10% | -83.7% |
| Q3 2015 | $5,469,000 | -27.7% | 30,526 | -10.0% | 0.59% | -23.1% |
| Q2 2015 | $7,568,000 | +14.5% | 33,915 | +1.5% | 0.77% | +15.5% |
| Q1 2015 | $6,611,000 | +309.3% | 33,408 | +195.6% | 0.66% | +307.4% |
| Q4 2014 | $1,615,000 | +17.5% | 11,300 | +7.6% | 0.16% | +14.0% |
| Q3 2014 | $1,374,000 | -25.6% | 10,500 | -28.1% | 0.14% | -17.8% |
| Q2 2014 | $1,847,000 | -60.8% | 14,600 | -59.3% | 0.17% | -63.3% |
| Q1 2014 | $4,716,000 | -9.4% | 35,832 | -19.3% | 0.47% | -11.2% |
| Q4 2013 | $5,207,000 | +7.3% | 44,416 | -4.5% | 0.53% | +122.5% |
| Q3 2013 | $4,853,000 | +7.1% | 46,516 | -11.4% | 0.24% | -56.0% |
| Q2 2013 | $4,530,000 | – | 52,506 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |